SCHEMBL18152647

SCHEMBL18152647

COc1c(C)cc[nH]c1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.35
NQO2 P16083 4/20 0.35
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
PARP1 P09874 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
POLB P06746 2/20 0.32
HPGD P15428 2/20 0.32
MAP2K7 O14733 1/20 0.32
GMNN O75496 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX15 P16050 1/20 0.32
CDC25A P30304 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12034737 0.79 PARP1 (0.41) CYP19A1NQO2KDM4EALDH1A1SMN1; SMN2
SCHEMBL31700720 0.74 KDM4E (0.35) KDM4EALDH1A1SMN1; SMN2PARP1L3MBTL1
SCHEMBL14848190 0.72 NAPRT (0.48) KDM4EALDH1A1SMN1; SMN2L3MBTL1POLB
SCHEMBL27298899 0.72 JAK2 (0.39) KDM4EALDH1A1SMN1; SMN2PARP1HPGD
SCHEMBL791101 0.72
SCHEMBL7413081 0.71 PDPK1 (0.39) PARP1L3MBTL1TUBB4ATUBBTUBA3C
SCHEMBL14829330 0.70 ALDH1A1 (0.52) KDM4EALDH1A1L3MBTL1POLBHPGD
SCHEMBL1053740 0.70 POLB (0.54) CYP19A1NQO2KDM4EALDH1A1SMN1; SMN2
SCHEMBL18257252 0.70 PDE3B (0.40) CYP19A1NQO2KDM4EALDH1A1PARP1
SCHEMBL3174185 0.69 SMN1; SMN2 (0.40) KDM4EALDH1A1SMN1; SMN2HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283077-A2 BROMODOMAIN INHIBITOR Celgene Quanticel Research, Inc. (US) 2018-02-21 EP disclosed
WO-2016168682-A2 BROMODOMAIN INHIBITOR CELGENE QUANTICEL RESEARCH, INC. (US) 2016-10-20 WO disclosed